Definium Therapeutics, Inc. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations
Definium Therapeutics, Inc. (DFTX) had Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations of $655.27 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations · last filed 2026-08-06
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $655.27M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $262.52M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $257.84M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $19.96M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations |
|---|---|
| 2026-06-30 | $655.27M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $262.52M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $257.84M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $19.96M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $33.39M 10-Q · filed 2026-08-06 |
| 2025-03-31 | $82.85M 10-Q · filed 2026-05-07 |
| 2024-12-31 | $273.74M 10-Q · filed 2026-08-06 |
| 2024-09-30 | $295.28M 10-Q · filed 2025-11-06 |
| 2024-06-30 | $243.13M 10-Q · filed 2025-07-31 |
| 2024-03-31 | $252.33M 10-Q · filed 2025-05-08 |
| 2023-12-31 | $99.70M 10-K · filed 2026-02-26 |
| 2023-09-30 | $117.70M 10-Q · filed 2024-11-07 |
| 2023-06-30 | $116.89M 10-Q · filed 2024-08-13 |
| 2023-03-31 | $129.41M 10-Q · filed 2024-05-08 |
| 2022-12-31 | $142.14M 10-K · filed 2025-03-06 |
| 2022-09-30 | $154.52M 10-Q · filed 2023-11-02 |
| 2022-06-30 | $105.74M 10-Q · filed 2023-08-03 |
| 2022-03-31 | $120.47M 10-Q · filed 2023-05-04 |
| 2021-12-31 | $133.54M 10-K · filed 2024-02-28 |
| 2021-09-30 | $145.92M 10-Q · filed 2022-11-10 |
| 2021-06-30 | $157.10M 10-Q · filed 2022-08-11 |
| 2021-03-31 | $160.04M 10-Q · filed 2022-05-16 |
| 2020-12-31 | $80.09M 10-K · filed 2023-03-09 |
| 2019-12-31 | $6.70M 10-K · filed 2022-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cronos Group Inc. (CRON) | $1.223B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B |